Article Correctness Is Author's Responsibility: Michigan Medicine helps lead national study on possible allergic reaction to COVID vaccine

(Michigan Medicine - University of Michigan) Researchers at Michigan Medicine are helping lead the first national study of how highly allergic people react to mRNA COVID-19 vaccines. The trial, co-led by a U-M immunologist, will cover over 3,000 participants receiving the Pfizer and Moderna vaccines at up to 35 academic allergy research centers across the United States.